Early Identification and Treatment of Pathogens in Sepsis: Molecular Diagnostics and Antibiotic Choice

Clinics in Chest Medicine

Volumn 37, Issue 2, 2016, Pages 191-207

  Riedel, Stefan ^a   Carroll, Karen C ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Antimicrobial stewardship; Bacteremia; Microarrays; Nucleic acid amplification; Patient outcomes; Resistance markers; Sepsis

Indexed keywords

PEPTIDE NUCLEIC ACID; ANTIINFECTIVE AGENT;

BACTEREMIA; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; DRUG CHOICE; EARLY DIAGNOSIS; EARLY INTERVENTION; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEPSIS; MOLECULAR PATHOLOGY; PATHOLOGY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; HUMANS; PATHOLOGY, MOLECULAR; SEPSIS;

EID: 84969640965     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2016.01.018     Document Type: Review

References (72)

1. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348(2):138-150.
2. Riedel S., Carroll K.C. Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med 2013, 33:413-437.
3. Chalupka A.N., Talmor D. The economics of sepsis. Crit Care Clin 2012, 28:57-76.
4. Sutton JP, Friedman B. Trends in septicemia hospitalizations and readmissions in selected HCUP States, 2005 and 2010. H-CUP, Healthcare Cost and Utilization Report; Statistical Brief 161, September 2013. Agency for Healthcare Research and Quality. Available at:. Accessed September 18, 2015. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb161.pdf.
5. Lagu T., Rothberg M.B., Nathanson B.H., et al. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med 2011, 171(4):292-299.
6. Tiru B., DiNino E.K., Orenstein A., et al. The economic and humanistic burden of severe sepsis. Pharmacoeconomics 2015, 33(9):925-937.
7. Stender H., Fiandaca M., Hyldig-Nielsen J.J., et al. PNA for rapid microbiology. J Microbiol Methods 2002, 48(1):1-17.
8. Avdic E., Carroll K.C. The role of the microbiology laboratory in antimicrobial stewardship programs. Infect Dis Clin North Am 2014, 28:215-235.
9. Hensley D.M., Tapia R., Encina Y. An evaluation of the AdvanDx Staphylococcus aureus/CNS PNA FISH assay. Clin Lab Sci 2009, 22(1):30-33.
10. Della-Latta P., Salimnia H., Painter T., et al. Identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa in blood cultures: a multicenter performance evaluation of a three-color peptide nucleic acid fluorescence in situ hybridization assay. J Clin Microbiol 2011, 49(6):2259-2261.
11. Morgan M.A., Marlowe E., Novak-Weekly S., et al. A 1.5 hour procedure for identification of Enterococcus species directly from blood cultures. J Vis Exp 2011, 48. [pii:2616].
12. Hall L., Le Febre K.M., Deml S.M., et al. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol 2012, 50(4):1446-1448.
13. Deck M.K., Anderson E.S., Buckner R.J., et al. Multicenter evaluation of the Staphylococcus QuickFISH method for simultaneous identification of Staphylococcus aureus and coagulase-negative staphylococci directly from blood culture bottles in less than 30 minutes. J Clin Microbiol 2012, 50(6):1994-1998.
14. Carretto E., Bardaro M., Russello G., et al. Comparison of the Staphylococcus QuickFISH BC test with the tube coagulase test performed on positive blood cultures for evaluation and application in a clinical routine setting. J Clin Microbiol 2013, 51(1):131-135.
15. Abdelhamed A.M., Zhang S.X., Watkins T., et al. Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles. J Clin Microbiol 2015, 53(5):1672-1676.
16. Salimnia H., Fairfax M.R., Lephart P., et al. An international, prospective, multicenter evaluation of the combination of the AdvanDx Staphylococcus QuickFISH BC with mecA XpressFISH for detection of methicillin-resistant Staphylococcus aureus isolates from positive blood cultures. J Clin Microbiol 2014, 52(11):3928-3932.
17. Nanosphere. Instrumentation 2015. Available at:. Accessed September 18, 2015. http://www.nanosphere.us/products/instrumentation.
18. Nanosphere. Products 2015. Available at:. Accessed September 18, 2015. http://www.nanosphere.us/products/bloodstream-infection-tests.
19. Beal S.G., Ciurca J., Smith G., et al. Evaluation of the Nanosphere Verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients. J Clin Microbiol 2013, 51(12):3988-3992.
20. Wojewoda C., Sercia L., Navas M., et al. Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J Clin Microbiol 2013, 51(7):2072-2076.
21. Samuel L.P., Tibbetts R.J., Agotesku A., et al. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol 2013, 51(4):1188-1192.
22. Hill J.T., Tran K.D., Barton K.L., et al. Evaluation of the Nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more rapid antibiotic interventions. J Clin Microbiol 2014, 52(10):3805-3807.
23. Dodemont M., De mendocena R., Nonhoff C., et al. Performance of the Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 2014, 52(8):3085-3087.
24. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
25. Pence M.A., TeKippe E.M., Burnham C.A. Diagnostic assays for identification of microorganisms and antimicrobial resistance determinants directly from positive blood culture broth. Clin Lab Med 2013, 33:651-684.
26. Buchan B.W., Allen S., Burnham C.A.D., et al. Comparison of the next-generation Xpert MRSA/SA BC assay and the GeneOhm StaphSR assay to routine culture for identification of Staphylococcus aureus and methicillin-resistant S. aureus in positive-blood-culture broths. J Clin Microbiol 2015, 53:804-809.
27. Loonen A.J.M., Wolffs P.F.G., Bruggeman C.A., et al. Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol 2014, 33:1687-1702.
28. Tissari P., Zumla A., Tarkka E., et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010, 375:224-230.
29. Aittakorpi A., Kuusela P., Koukila-Kähkölä P., et al. Accurate ad rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it sepsis assay. J Clin Microbiol 2012, 50:3635-3640.
30. Blaschke A.J., Heyrend C., Byington C.L., et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012, 74:349-355.
31. Altun O., Almuhayawi M., Ullberg M., et al. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol 2013, 51:4130-4136.
32. Kanack KJ, Salimnia H, Schreckenberger P, et al. Clinical evaluation of a multiplex PCR blood culture identification panel for simultaneous detection of bacteria, yeast and select antimicrobial resistance genes. Abstract presented at the 53rd Intersci Conf Antimicrob Agents Chemother, abstract D-104. Denver, CO, September 10-13, 2013.
33. Bhatti M.M., Boonlayangoor S., Beavis K.G., et al. Evaluation of the FilmArray and Verigene Systems for rapid identification of positive blood cultures. J Clin Microbiol 2014, 52:3433-3436.
34. ® blood culture identification panel with antimicrobial treatment recommendations for bloodstream infections at a Midwestern academic tertiary hospital. Diagn Microbiol Infect Dis 2015, 81:96-101.
35. Ward C., Stocker K., Begum J., et al. Performance of the Verigene (Nanosphere) and FilmArray (BioFire) molecular assays for identification of causative organisms in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2015, 34:487-496.
36. Aellen S., Que Y.A., Guignard B., et al. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrob Agents Chemother 2006, 50:1913-1920.
37. BioFire Diagnostics LLC. Advisory notice. 2014. Available at:. Accessed December 10, 2015. ftp://ftp.bmgrp.at/Austria/BioFire-BCID-Lit/Manuals-Beipacktexte/rfit-prt-0224_fa_bcid_ce:ivd_reag_doc_en.pdf.
38. Jonsson B., Nyberg A., Henning C. Theoretical aspects of detection of bacteraemia as a function of volume of blood cultured. APMIS 1993, 101:595-601.
39. Birch L., Dawson C.E., Cornett J.H., et al. A comparison of nucleic acid amplification techniques for the assessment of bacterial viability. Lett Appl Microbiol 2001, 33:296-301.
40. Skvarc M., Stubljar D., Rogina P., et al. Non-culture-based methods to diagnose bloodstream infection: does it work?. Eur J Microbiol Immunol 2013, 2:97-104.
41. Chang S.S., Hsieh W.H., Liu T.S., et al. Multiplex PCR system for rapid detection of pathogens is patients with presumed sepsis-a systematic review and meta-analysis. PLoS One 2013, 8:1-10.
42. ® SeptiFast for the detection and identification of pathogens in blood of patients with suspected sepsis: a systematic review and meta-analysis. Intensive Care Med 2015, 41:21-33.
43. Wellinghausen N., Kochem A.-J., Disqué C., et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16SrRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009, 47:2759-2765.
44. Bloos F., Sachse S., Kortgen A., et al. Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS One 2012, 7:e46003.
45. Carrara L., Navarro F., Turbau M., et al. Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay. J Med Microbiol 2013, 62:1673-1679.
46. Ljungstrom L., Enroth H., Claesson B.E.B., et al. Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis. BMC Infect Dis 2015, 15:199-209.
47. Neely L.A., Audeh M., Phung N.A., et al. T2 Magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 2013, 5:182-54.
48. Mylonakis E., Clancy C.J., Ostrosky-Zeichner L., et al. T2 Magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 2015, 60:892-899.
49. Ecker D.J., Sampath R., Massire C., et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008, 6(7):553-558.
50. Ecker D.J., Sampath R., Li H., et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn 2010, 10:399-415.
51. Kaleta E.J., Clark A.E., Johnson D.R., et al. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol 2011, 49:345-353.
52. Laffler T.G., Cummins L.L., McClain C.M., et al. Enhanced diagnostic yields of bacteremia and candidemia in blood specimens by PCR/electrospray ionization mass spectrometry. J Clin Microbiol 2013, 51:3535-3541.
53. Bacconi A., Richmond G.A., Baroldi M.A., et al. Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol 2014, 52:3164-3174.
54. Vincent J.L., Brealey D., Libert N., et al. Rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit Care Med 2015, 43:2283-2291.
55. Camins B.C., King M.D., Wells J.B., et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol 2009, 30:931-938.
56. Nowak M.A., Nelson R.E., Breidenbach J.L., et al. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm 2012, 69:1500-1508.
57. Murray P.R., Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections for the ICU. Crit Care Med 2012, 40(12):3277-3282.
58. Previsdomini M., Gini M., Cerutti B., et al. Predictors of positive blood cultures in critically ill patients: a retrospective evaluation. Croat Med J 2012, 53(1):30-39.
59. Forrest G.N., Mehta S., Weekes E., et al. Impact of in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 2006, 58:154-158.
60. Ly T., Gulia J., Pyrgos V., et al. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008, 4(3):637-640.
61. Forrest G.N., Roghmann M.C., Toombs L.S., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52(10):3558-3563.
62. Forrest G.N., Mankes K., Jabra-Rizk M.A., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal costs. J Clin Microbiol 2006, 44(9):3381-3383.
63. Holtzman C., Whitney D., Barlam T., et al. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 2011, 49(4):1581-1582.
64. Bauer K.A., West J.E., Balada-Llasat J.M., et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010, 51(9):1074-1080.
65. Alby K., Daniels L.M., Weber D.J., et al. Development of a treatment algorithm for streptococci and enterococci from positive blood cultures identified with the Verigene Gram-positive blood culture assay. J Clin Microbiol 2013, 51(11):3869-3971.
66. Sango A., McCarter Y.S., Johnson D., et al. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol 2013, 51(12):4008-4011.
67. Beal S.G., Thomas C., Dhiman N., et al. Antibiotic utilization improvement with the Nanosphere Verigene Gram-positive blood culture assay. Proc (Bayl Univ Med Cent) 2015, 28(2):139-143.
68. Bork J.T., Leekha S., Heil E.L., et al. Rapid testing using the Verigene gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against gram-negative bacteremia. Antimicrob Agents Chemother 2015, 59(3):1588-1595.
69. Ledeboer N.A., Lopansri B.K., Dhiman N., et al. Identification of gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the Verigene gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol 2015, 53(8):2460-2472.
70. Banerjee R., Teng C.B., Cunningham S.A., et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 2015, 61:1071-1080.
71. Harbarth S., Nobre V., Pittet D. Does antibiotic selection impact patient outcome?. Clin Infect Dis 2007, 44:87-93.
72. Bilir S.P., Ferrufino C.P., Pfaller M.A., et al. The economic impact of rapid Candida species identification by T2Candida among high risk patients. Future Microbiol 2015, 10(7):1133-1144.